Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 623 | 3 | 0.5 | 131 | 21.0 | 157 | 25.2 | 274 | 44.0 | 58 | 9.3 |
2015-2019 | 599 | 3 | 0.5 | 121 | 20.2 | 141 | 23.5 | 260 | 43.4 | 74 | 12.4 |
2014-2018 | 615 | 3 | 0.5 | 114 | 18.5 | 134 | 21.8 | 266 | 43.3 | 98 | 15.9 |
2013-2017 | 622 | 2 | 0.3 | 117 | 18.8 | 133 | 21.4 | 273 | 43.9 | 97 | 15.6 |
2012-2016 | 640 | 2 | 0.3 | 122 | 19.1 | 142 | 22.2 | 280 | 43.8 | 94 | 14.7 |
2011-2015 | 637 | 2 | 0.3 | 109 | 17.1 | 135 | 21.2 | 287 | 45.1 | 104 | 16.3 |
2010-2014 | 638 | 2 | 0.3 | 121 | 19.0 | 136 | 21.3 | 279 | 43.7 | 100 | 15.7 |
2009-2013 | 633 | 2 | 0.3 | 130 | 20.5 | 141 | 22.3 | 284 | 44.9 | 76 | 12.0 |
2008-2012 | 644 | 2 | 0.3 | 133 | 20.7 | 144 | 22.4 | 281 | 43.6 | 84 | 13.0 |
2007-2011 | 645 | 2 | 0.3 | 126 | 19.5 | 147 | 22.8 | 262 | 40.6 | 108 | 16.7 |
2006-2010 | 603 | 1 | 0.2 | 106 | 17.6 | 144 | 23.9 | 237 | 39.3 | 115 | 19.1 |
2005-2009 | 602 | - | - | 89 | 14.8 | 148 | 24.6 | 231 | 38.4 | 134 | 22.3 |
2004-2008 | 599 | - | - | 77 | 12.9 | 154 | 25.7 | 222 | 37.1 | 146 | 24.4 |
2003-2007 | 561 | - | - | 66 | 11.8 | 148 | 26.4 | 197 | 35.1 | 150 | 26.7 |
2002-2006 | 516 | - | - | 62 | 12.0 | 139 | 26.9 | 187 | 36.2 | 128 | 24.8 |
2001-2005 | 527 | - | - | 66 | 12.5 | 151 | 28.7 | 194 | 36.8 | 116 | 22.0 |
2000-2004 | 515 | - | - | 67 | 13.0 | 150 | 29.1 | 201 | 39.0 | 97 | 18.8 |
1999-2003 | 506 | - | - | 74 | 14.6 | 154 | 30.4 | 187 | 37.0 | 91 | 18.0 |
1998-2002 | 528 | - | - | 85 | 16.1 | 158 | 29.9 | 207 | 39.2 | 78 | 14.8 |
1997-2001 | 529 | - | - | 80 | 15.1 | 158 | 29.9 | 205 | 38.8 | 86 | 16.3 |
1996-2000 | 534 | - | - | 90 | 16.9 | 153 | 28.7 | 201 | 37.6 | 90 | 16.9 |
1995-1999 | 545 | - | - | 87 | 16.0 | 151 | 27.7 | 197 | 36.1 | 110 | 20.2 |
1994-1998 | 526 | - | - | 78 | 14.8 | 129 | 24.5 | 200 | 38.0 | 119 | 22.6 |
1993-1997 | 509 | 2 | 0.4 | 71 | 13.9 | 126 | 24.8 | 182 | 35.8 | 128 | 25.1 |
1992-1996 | 522 | 2 | 0.4 | 71 | 13.6 | 117 | 22.4 | 193 | 37.0 | 139 | 26.6 |
1991-1995 | 499 | 2 | 0.4 | 56 | 11.2 | 106 | 21.2 | 183 | 36.7 | 152 | 30.5 |
1990-1994 | 464 | 2 | 0.4 | 63 | 13.6 | 95 | 20.5 | 156 | 33.6 | 148 | 31.9 |
1989-1993 | 444 | 2 | 0.5 | 63 | 14.2 | 94 | 21.2 | 139 | 31.3 | 146 | 32.9 |
1988-1992 | 420 | - | - | 55 | 13.1 | 85 | 20.2 | 130 | 31.0 | 150 | 35.7 |
1987-1991 | 368 | - | - | 47 | 12.8 | 74 | 20.1 | 110 | 29.9 | 137 | 37.2 |
1986-1990 | 342 | - | - | 44 | 12.9 | 65 | 19.0 | 101 | 29.5 | 132 | 38.6 |
1985-1989 | 310 | - | - | 29 | 9.4 | 51 | 16.5 | 101 | 32.6 | 129 | 41.6 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |